8-{5-[4-(Trifluoromethyl)phenyl]oxazol-2-ylamino}-3,4-dihydronaphthalen-2(1H)-one → 8-(5-p-Tolyloxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol

참여 물질

반응 단계

The title compound was prepared using the procedure as described in Example 2, substituting the product of Example 9C for the product of Example 1I. 1H NMR (DMSO-d6) δ 9.05 (s, 1H), 7.58 (m, 1H), 7.44 (m, 2H), 7.29 (s, 1H), 7.19 (m, 2H), 7.06 (t, 1H, J=7.5 Hz), 6.83 (d, 1H, J=7.0 Hz), 4.80 (d, 1H, J=4.0 Hz), 3.92 (m, 1H), 2.72-2.96 (m, 4H), 2.31 (s, 3H), 1.84 (m, 1H), 1.63 (m, 1H); MS (ESI+) m/z 321 (M+H).

출처 및 근거